Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.430
+0.050 (2.10%)
Nov 22, 2024, 4:00 PM EST - Market closed

Seer, Inc. Revenue

Seer, Inc. had revenue of $4.03M in the quarter ending September 30, 2024, a decrease of -3.12%. This brings the company's revenue in the last twelve months to $14.61M, down -13.19% year-over-year. In the year 2023, Seer, Inc. had annual revenue of $16.66M with 7.54% growth.

Revenue (ttm)
$14.61M
Revenue Growth
-13.19%
P/S Ratio
10.58
Revenue / Employee
$99,374
Employees
147
Market Cap
143.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202316.66M1.17M7.54%
Dec 31, 202215.49M8.88M134.14%
Dec 31, 20216.62M5.96M908.69%
Dec 31, 2020656.00K540.00K465.52%
Dec 31, 2019116.00K--
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Seres Therapeutics 126.33M
Fennec Pharmaceuticals 49.35M
Cidara Therapeutics 44.65M
Sensus Healthcare 41.31M
TriSalus Life Sciences 26.89M
Elutia 24.78M
Vaxart 16.76M
Revenue Rankings